Woo H. Shin, Ph.D., Executive Director, is the founder of SnK Associate Inc., a business development consulting firm in the healthcare industry, which works on numerous assignments between Asia and North America. Dr. Shin has a wide range of experience in the pharmaceutical industry covering areas such as patents, clinical trials, regulatory works, as well as the drug discovery process. With his broad networks in science, business and the financial world, Dr. Shin not only consults with small biotech companies to identify funding, to build strategic plans, and to partner their technologies, but also assists investment organizations to source and assess promising companies/technologies.

Before founding SnK Associates, Dr. Shin was Director of Business Development and Operations at the SK R&D Center, where he was instrumental in closing two successful deals with Ortho-McNeal Pharmaceutical and Janssen. At the SK R&D center, Dr. Shin started as a senior research scientist working on automation projects for factory processes, QC, and analytical assays. During this period, he helped to meet the numerous technology transfer needs of the SK group, one of the largest conglomerates in Korea.

Dr. Shin received a BS in chemistry from Seoul National University, Korea and a PhD' in chemistry from Michigan State University.